Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
/in Chronic Virus Hepatitis, International Publications /von 2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection
/in Chronic Virus Hepatitis, International Publications /von 2005-11-01 / Clin. Exp. Immunol. 2005 Nov;142(2):362-9Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity
/in Chronic Virus Hepatitis, International Publications /von 2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-81[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte]
/in Chronic Virus Hepatitis, International Publications /von 2005-05-11 / Zhonghua Yi Xue Za Zhi 2005 May;85(17):1171-6Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study
/in Chronic Virus Hepatitis, International Publications /von 2005-03-28 / World J. Gastroenterol. 2005 Mar;11(12):1806-8Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor
/in Chronic Virus Hepatitis, International Publications /von 2005-01-28 / World J. Gastroenterol. 2005 Jan;11(4):557-60Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
/in Chronic Virus Hepatitis, International Publications /von 2005-01-18 / Blood 2005 May;105(9):3605-14Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
/in Chronic Virus Hepatitis, International Publications /von 2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-9Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
/in Chronic Virus Hepatitis, International Publications /von 2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-90
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution